Ingersoll (IR) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Ingersoll (IR) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Ingersoll Rand (IR) Surpasses Q4 Earnings and Revenue Estimates
Ingersoll Rand (IR) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.84 per share a year ago.
Wall Street's Insights Into Key Metrics Ahead of Ingersoll (IR) Q4 Earnings
Evaluate the expected performance of Ingersoll (IR) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Ingersoll Rand (IR) Reports Next Week: Wall Street Expects Earnings Growth
Ingersoll (IR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ingersoll (IR) Surges 5.4%: Is This an Indication of Further Gains?
Ingersoll (IR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Ingersoll Rand Inc. (IR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Ingersoll Rand Inc. (IR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Ingersoll Rand Acquires Scinomix, Strengthens Life Sciences Portfolio
IR strengthens its life sciences platform by acquiring Scinomix, adding automation workflow technologies for labs and pharma markets.
Here's Why You Should Retain Ingersoll Rand in Your Portfolio
IR sees order growth and acquisitions lift 2025 outlook, while cash flow supports buybacks despite rising costs.
Reasons Why You Should Avoid Betting on Ingersoll Rand Right Now
IR struggles with rising costs, mounting debt and currency headwinds, pressuring profitability and investor sentiment.
Ingersoll Rand's Q3 Earnings Match Estimates, Revenues Beat
IR posts solid Q3 results with revenues up 5.1% and earnings matching estimates, but trims full-year EPS outlook.
Ingersoll Rand Inc. (IR) Q3 2025 Earnings Call Transcript
Ingersoll Rand Inc. ( IR ) Q3 2025 Earnings Call October 31, 2025 8:00 AM EDT Company Participants Matthew Fort - VP of Investor Relations, Global Financial Planning & Analysis Vicente Reynal - Chairman, CEO & President Vikram Kini - Senior VP & CFO Conference Call Participants Michael Halloran - Robert W. Baird & Co. Incorporated, Research Division Julian Mitchell - Barclays Bank PLC, Research Division Jeffrey Sprague - Vertical Research Partners, LLC Andrew Kaplowitz - Citigroup Inc., Research Division Nigel Coe - Wolfe Research, LLC Joseph Ritchie - Goldman Sachs Group, Inc., Research Division Christopher Snyder - Morgan Stanley, Research Division Stephen Volkmann - Jefferies LLC, Research Division Joseph O'Dea - Wells Fargo Securities, LLC, Research Division Nathan Jones - Stifel, Nicolaus & Company, Incorporated, Research Division Nicole DeBlase - Deutsche Bank AG, Research Division David Raso - Evercore ISI Institutional Equities, Research Division Presentation Operator Hello, and thank you for standing by.
Compared to Estimates, Ingersoll (IR) Q3 Earnings: A Look at Key Metrics
The headline numbers for Ingersoll (IR) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
